Ignite Planners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
9,275
+268
+3% +$37.5K 0.2% 124
2025
Q4
$1.28M Buy
9,007
+1,075
+14% +$131K 0.2% 122
2025
Q3
$880K Buy
7,932
+86
+1% +$9.78K 0.14% 151
2025
Q2
$849K Buy
7,846
+73
+0.9% +$7.77K 0.15% 149
2025
Q1
$803K Buy
7,773
+880
+13% +$90.8K 0.16% 144
2024
Q4
$630K Sell
6,893
-19
-0.3% -$1.71K 0.14% 142
2024
Q3
$579K Buy
6,912
+8
+0.1% +$610 0.13% 152
2024
Q2
$460K Sell
6,904
-480
-7% -$32K 0.11% 166
2024
Q1
$538K Sell
7,384
-1,412
-16% -$109K 0.15% 145
2023
Q4
$732K Sell
8,796
-753
-8% -$58.6K 0.22% 114
2023
Q3
$713K Buy
9,549
+1,116
+13% +$85.8K 0.22% 117
2023
Q2
$628K Sell
8,433
-109
-1% -$8.69K 0.24% 96
2023
Q1
$706K Buy
8,542
+364
+4% +$30.1K 0.29% 85
2022
Q4
$686K Buy
+8,178
New +$648K 0.29% 90

Other funds holding GILD

Ignite Planners's GILD Position: Q1 2026 in Review

Ignite Planners increased its Gilead Sciences (GILD) stake by 3% in Q1 2026, buying an estimated $37.5K and bringing the position to 9,275 shares worth $1.29M. The position accounts for 0.2% of the portfolio, ranked #124.

Ignite Planners first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ignite Planners held 9,275 shares of Gilead Sciences worth $1.29M as of Q1 2026.
  • Ignite Planners bought 268 Gilead Sciences shares in Q1 2026, an estimated $37.5K.
  • Gilead Sciences made up 0.2% of Ignite Planners's portfolio in Q1 2026, its #124 holding.
  • Ignite Planners first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ignite Planners's 13F filing for Q1 2026, filed 17 Apr 2026.